Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Morgan Stanley
MS
|
$1.57B |
| 2 |
Eli Lilly
LLY
|
$1.32B |
| 3 |
Baxter International
BAX
|
$1.01B |
| 4 |
Charles Schwab
SCHW
|
$902M |
| 5 |
RTX Corp
RTX
|
$798M |
Top Sells
| 1 |
Intel
INTC
|
$1.52B |
| 2 |
Apple
AAPL
|
$1.34B |
| 3 |
Deere & Co
DE
|
$1.16B |
| 4 |
American Tower
AMT
|
$989M |
| 5 |
McDonald's
MCD
|
$983M |
Sector Composition
| 1 | Healthcare | 22.81% |
| 2 | Technology | 18.46% |
| 3 | Financials | 13.39% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 10.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
RTX Corp
RTX
$212B
| $3.92B | 0.72% | 54,784,814 +11,155,762 | +26% | +$798M |
|
27
Lockheed Martin
LMT
$106B
| $3.81B | 0.7% | 10,735,022 +35,877 | +0.3% | +$12.7M |
|
28
Cisco
CSCO
$274B
| $3.75B | 0.69% | 83,868,156 +650,674 | +0.8% | +$29.1M |
|
29
Blackrock
BLK
$175B
| $3.52B | 0.65% | 4,876,344 -253,516 | -5% | -$183M |
|
30
Abbott
ABT
$231B
| $3.41B | 0.63% | 31,182,319 -3,823,064 | -11% | -$419M |
|
31
Thermo Fisher Scientific
TMO
$186B
| $3.4B | 0.63% | 7,300,166 -425,422 | -6% | -$198M |
|
32
Becton Dickinson
BDX
$55.3B
| $3.37B | 0.62% | 13,452,781 +1,890,980 | +16% | +$473M |
|
33
Progressive
PGR
$145B
| $3.36B | 0.62% | 34,012,839 -4,538,493 | -12% | -$449M |
|
34
Merck
MRK
$210B
| $3.33B | 0.61% | 40,661,969 -4,067,397 | -9% | -$333M |
|
|
35
Baxter International
BAX
$12.7B
| $3.32B | 0.61% | 41,365,746 +12,620,732 | +44% | +$1.01B |
|
36
Texas Instruments
TXN
$184B
| $3.22B | 0.59% | 19,631,324 -985,994 | -5% | -$162M |
|
37
Elevance Health
ELV
$71.8B
| $3.21B | 0.59% | 10,003,834 +498,228 | +5% | +$160M |
|
38
Exelon
EXC
$44.1B
| $3.18B | 0.59% | 75,359,646 -2,724,911 | -3% | -$115M |
|
39
Visa
V
$683B
| $3.1B | 0.57% | 14,178,107 -50,681 | -0.4% | -$11.1M |
|
|
40
Deere & Co
DE
$130B
| $3.02B | 0.56% | 11,211,907 -4,294,151 | -28% | -$1.16B |
|
41
Nike
NKE
$114B
| $2.91B | 0.54% | 20,562,295 -688,014 | -3% | -$97.3M |
|
42
HCA Healthcare
HCA
$94.5B
| $2.9B | 0.53% | 17,655,304 -1,352,748 | -7% | -$222M |
|
43
Bristol-Myers Squibb
BMY
$96B
| $2.84B | 0.52% | 45,743,475 -8,244,932 | -15% | -$511M |
|
44
Honeywell
HON
$139B
| $2.82B | 0.52% | 13,253,509 -963,628 | -7% | -$205M |
|
45
PepsiCo
PEP
$204B
| $2.79B | 0.51% | 18,782,311 -72,403 | -0.4% | -$10.7M |
|
46
Boston Scientific
BSX
$156B
| $2.78B | 0.51% | 77,265,641 +18,663,851 | +32% | +$671M |
|
47
Blackstone
BX
$134B
| $2.77B | 0.51% | 42,735,373 -168,828 | -0.4% | -$10.9M |
|
48
Northrop Grumman
NOC
$84.5B
| $2.75B | 0.51% | 9,025,016 -631,682 | -7% | -$192M |
|
49
Accenture
ACN
$162B
| $2.73B | 0.5% | 10,437,350 -99,119 | -0.9% | -$25.9M |
|
50
Duke Energy
DUK
$95.3B
| $2.71B | 0.5% | 29,561,328 +109,190 | +0.4% | +$10M |
|